Posted on 6/10/20
Immunic Announces Proposed Public Offering of Common Stock
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced it . . .
Posted on 6/10/20
Immunic Announces Pricing of $25 Million Public Offering of Common Stock
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the . . .
Posted on 6/10/20
Neurotrope Announces Strategic Partnership with BryoLogyx
Neurotrope, Inc. (Nasdaq: NTRP) today announced its entry into a strategic agreement with BryoLogyx Inc., www.BryoLogyx.com, for the supply of synthetic, GMP-certified Bryostatin-1, manufactured by Albany . . .
Posted on 6/10/20
XpresSpa Announces 1-for-3 Reverse Stock Split
NEW YORK, June 10, 2020 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA), a health and wellness company, today announced that it filed a certificate of . . .
Posted on 6/10/20
States with the Biggest Health Improvements During COVID-19 – WalletHub Study
With new COVID-19 cases trending downward and states’ infection and death rates dictating the pace at which they can reopen their economies, WalletHub today released its . . .
Posted on 6/10/20
Here's Why TG Therapeutics Jumped 58.6% in May
What happenedShares of TG Therapeutics (NASDAQ:TGTX) rose over 58% last month, according to data from S&P Global Market Intelligence. Most of the gains were spurred by . . .
Posted on 6/9/20
Legend Biotech Corp. Closes IPO
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology . . .
Posted on 6/9/20
Vita Healthcare Group Salutes its Frontline Workers at Potomac Valley Rehabilitation and Healthcare Center
Vita Healthcare Group is grateful for our team members on the frontlines as we continue to battle the COVID-19 crisis. The Vita Strike Team continuously rises . . .
Posted on 6/9/20
IAB Tech Lab Increases Investment and Presence in Europe
IAB Tech Lab (Tech Lab), the digital media and marketing industry's global nonprofit research, development, and technical standards-setting consortium, today announced that vonwerschpartner Digital Strategies (vonwerschpartner) . . .
Posted on 6/9/20
Concourse Labs Raises $15.2 Million in Series A Funding led by ForgePoint Capital
Concourse Labs, a company that accelerates enterprise digital transformation through automated cloud governance today emerged from stealth mode announcing $15.2 million in Series A funding.
Posted on 6/9/20
2 Top Pharma Stocks to Buy in June
Stocks are in a precarious place at the moment. Most U.S. companies are no longer trading on anything close to their underlying fundamentals, but rather on . . .
Posted on 6/8/20
3 Top Biotech Stocks to Buy in June
Investors seeking to beat the market should take a long and hard look at biotech stocks. That's especially true during times when there's a lot of . . .
Posted on 6/8/20
The #1 Pick In Health Care: Johnson & Johnson
SummaryJohnson & Johnson is undervalued against an expensive U.S. stock market, with a lower P/E and higher dividend yield.Diversified consumer/pharma/medical product sales are as close to . . .
Posted on 6/8/20
Better Buy: AbbVie vs. Johnson & Johnson
AbbVie (NYSE:ABBV) and Johnson & Johnson (NYSE:JNJ) are stalwart companies that are in a lot of investors' portfolios. Analysts almost always preach diversification, and these two . . .
Posted on 6/8/20
Disruptor Alert: These 3 Companies Are Changing Healthcare
The U.S. population is aging and expected to continue getting older for the foreseeable future. As demand on the system causes prices to steadily rise, pressure . . .
Posted on 6/5/20
Memorial Sloan Kettering - Hackensack Meridian Health Partnership Announces Funding for Inaugural Immunology Research Collaboration Projects
As part of the Memorial Sloan Kettering – Hackensack Meridian Health Partnership, the two organizations have formed an Immunology Research Collaboration. Through this joint initiative, researchers . . .
Posted on 6/5/20
DLA Piper Advises Iovance Biotherapeutics in its $604M Common Stock Offering
DLA Piper represented Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), in a US$603.7 million . . .
Posted on 6/5/20
Acacia Agrees to Acquire Portfolio of Life Science Assets for £223.9 million
NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG), a publicly-traded investor in absolute return assets, today announced that it had entered into an agreement with Link Fund Solutions . . .
Posted on 6/5/20
UCB Acquires Engage Therapeutics
UCB announced today the acquisition of Engage Therapeutics, Inc. (Summit, N.J. (U.S.)), a clinical-stage pharmaceutical company developing Staccato Alprazolam for the rapid termination of an active epileptic . . .
Posted on 6/5/20
Better Buy: Bristol Myers Squibb vs. Gilead Sciences
There are few names more well-known in the biopharmaceutical world than Bristol Myers Squibb (NYSE:BMY) and Gilead Sciences (NASDAQ:GILD). While neither stock was immune to the . . .
Posted on 6/4/20
Potomac Valley Rehabilitation and Healthcare Residents Enjoy Virtual Visits with Family & Friends
As we continue social distancing, human connection is still crucial. Throughout the COVID-19 pandemic, Potomac Valley Rehabilitation and Healthcare residents have enjoyed virtual visits with family . . .
Posted on 6/3/20
Cities with the Biggest Increases in Unemployment Rates Due to COVID-19 – WalletHub Study
With certain businesses reopening all across the country in an effort to reverse some of the nearly 41 million job losses caused by the coronavirus pandemic, . . .
Posted on 6/3/20
Johnson & Johnson: Built To Last
SummaryJohnson & Johnson is built to last with diverse revenue streams and strong competitive advantages in many of its markets.It has performed well both during the . . .
Posted on 6/3/20
Are Pfizer's Growth Prospects in Trouble With Its Shocking Ibrance Setback?
Pfizer (NYSE:PFE) started off the month of June with a bombshell. The big drugmaker announced disappointing news on Monday from its Pallas late-stage study evaluating Ibrance . . .
Posted on 6/2/20
PCI Pharma Services and Experic Announce Strategic Collaboration
PHILADELPHIA & CRANBURY, N.J.--(BUSINESS WIRE)--PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, and Experic, a contract manufacturing organization (CMO) and pharmaceutical . . .

